116P Any regression of tumor (ART) as an intermediate endpoint in patients (pts) treated with immune checkpoint inhibitors (ICI): A pan-cancer analysis.
Saved in:
| Title: | 116P Any regression of tumor (ART) as an intermediate endpoint in patients (pts) treated with immune checkpoint inhibitors (ICI): A pan-cancer analysis. |
|---|---|
| Authors: | El Zarif, T.1 (AUTHOR), Pond, G.2 (AUTHOR), Nassar, A.3 (AUTHOR), Adib, E.3 (AUTHOR), Freeman, D.1 (AUTHOR), Thomas, J.4 (AUTHOR), Kalluri, U.5 (AUTHOR), Matar, A.6 (AUTHOR), Kelly, E.7 (AUTHOR), Curran, C.1 (AUTHOR), Kadamkulam Syriac, A.8 (AUTHOR), McClure, H.1 (AUTHOR), Davidsohn, M.1 (AUTHOR), Labaki, C.1 (AUTHOR), Saliby, R.M.1 (AUTHOR), Hobeika, C.S.3 (AUTHOR), Nuzzo, P.V.1 (AUTHOR), Berchuck, J.E.9 (AUTHOR), Choueiri, T.K.10 (AUTHOR), Sonpavde, G.P.11 (AUTHOR) |
| Source: | Annals of Oncology. 2022 Supplement 7, Vol. 33, pS591-S592. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 159076949 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 116P Any regression of tumor (ART) as an intermediate endpoint in patients (pts) treated with immune checkpoint inhibitors (ICI): A pan-cancer analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22El+Zarif%2C+T%2E%22">El Zarif, T.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pond%2C+G%2E%22">Pond, G.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nassar%2C+A%2E%22">Nassar, A.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Adib%2C+E%2E%22">Adib, E.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Freeman%2C+D%2E%22">Freeman, D.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Thomas%2C+J%2E%22">Thomas, J.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kalluri%2C+U%2E%22">Kalluri, U.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Matar%2C+A%2E%22">Matar, A.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kelly%2C+E%2E%22">Kelly, E.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Curran%2C+C%2E%22">Curran, C.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kadamkulam+Syriac%2C+A%2E%22">Kadamkulam Syriac, A.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22McClure%2C+H%2E%22">McClure, H.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Davidsohn%2C+M%2E%22">Davidsohn, M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Labaki%2C+C%2E%22">Labaki, C.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Saliby%2C+R%2EM%2E%22">Saliby, R.M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hobeika%2C+C%2ES%2E%22">Hobeika, C.S.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nuzzo%2C+P%2EV%2E%22">Nuzzo, P.V.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Berchuck%2C+J%2EE%2E%22">Berchuck, J.E.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Choueiri%2C+T%2EK%2E%22">Choueiri, T.K.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sonpavde%2C+G%2EP%2E%22">Sonpavde, G.P.</searchLink><relatesTo>11</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2022 Supplement 7, Vol. 33, pS591-S592. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=159076949 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2022.07.148 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S591 Titles: – TitleFull: 116P Any regression of tumor (ART) as an intermediate endpoint in patients (pts) treated with immune checkpoint inhibitors (ICI): A pan-cancer analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: El Zarif, T. – PersonEntity: Name: NameFull: Pond, G. – PersonEntity: Name: NameFull: Nassar, A. – PersonEntity: Name: NameFull: Adib, E. – PersonEntity: Name: NameFull: Freeman, D. – PersonEntity: Name: NameFull: Thomas, J. – PersonEntity: Name: NameFull: Kalluri, U. – PersonEntity: Name: NameFull: Matar, A. – PersonEntity: Name: NameFull: Kelly, E. – PersonEntity: Name: NameFull: Curran, C. – PersonEntity: Name: NameFull: Kadamkulam Syriac, A. – PersonEntity: Name: NameFull: McClure, H. – PersonEntity: Name: NameFull: Davidsohn, M. – PersonEntity: Name: NameFull: Labaki, C. – PersonEntity: Name: NameFull: Saliby, R.M. – PersonEntity: Name: NameFull: Hobeika, C.S. – PersonEntity: Name: NameFull: Nuzzo, P.V. – PersonEntity: Name: NameFull: Berchuck, J.E. – PersonEntity: Name: NameFull: Choueiri, T.K. – PersonEntity: Name: NameFull: Sonpavde, G.P. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2022 Supplement 7 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 33 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
